Our Stock of the Week is Absci Corporation (ABSI). Absci uses artificial intelligence to design antibody drugs, and its lead drug, ABS-201, is an injection for common hair loss that may need to be given only two or three times over six months. The first results on...

Our Stock of the Week is Space Exploration Technologies (SPCX). A much-ballyhooed IPO this summer, SPCX priced at $135 on June 12 in the largest offering in market history and closed its first day at about $161. As is the case with most IPOs, the stock cooled quickly...

Our Stock of the Week is Oscar Health, Inc. (OSCR). Oscar is a technology-led health insurer offering individual and family health plans, along with its +Oscar platform that licenses its technology stack to other players in the healthcare system. An IPO back in 2021,...

Our Stock of the Week is Amazon.com, Inc. (AMZN). A top-performing stock over the past 25 years, AMZN is the world's largest e-commerce retailer and, through AWS, one of the two dominant cloud infrastructure providers, with a fast-growing advertising business to boot....

Our Stock of the Week is Hewlett Packard Enterprise (HPE). We highlighted this name earlier this month, but as a reminder, over the past few years, HPE has transformed itself from a slow-growth legacy hardware company into a major player in enterprise data center and...

Our Stock of the Week is Hinge Health, Inc. (HNGE). Hinge Health is a digital healthcare company that provides virtual physical therapy and wearable technology to help patients manage chronic, acute, or post-surgical back, joint, and muscle pain from home, primarily...

Our Stock of the Week is Precigen (PGEN), which makes PAPZIMEOS, a gene therapy approved a year ago as the first treatment for recurrent respiratory papillomatosis. HPV causes growths to keep returning in the airway, and until last August the only option was surgery,...

Our Stock of the Week is Definium Therapeutics (DFTX). It was our Stock of the Week back on June 15, but as a reminder, Definium Therapeutics is a late-stage clinical biopharmaceutical company whose lead candidate is a pharmaceutically optimized form of LSD (DT120,...

Our Stock of the Week is Hewlett Packard Enterprise (HPE). HPE has transformed itself from a slow-growth legacy hardware company into a major player in enterprise data center and computing infrastructure, positioning itself as an “edge-to-cloud hybrid infrastructure”...

Our Stock of the Week is Candel Therapeutics (CADL). Candel is a clinical-stage biopharmaceutical company developing off-the-shelf immunotherapies for cancer, with its lead candidate aglatimagene besadenovec (CAN-2409) which has already posted positive Phase 3 results...